Detection of Herpes Virus DNA in Post-operative Thyroid Tissue Specimens of Patients with Autoimmune Thyroid Disease

Abstract

Aim: To demonstrate any differences in the detection of herpes simplex virus type 1 and 2, cytomegalovirus, human herpes virus type 6 and 7 DNA from thyroid tissue blocks of patients with autoimmune thyroid disease and multi-nodular goiter and to propose few mechanisms, which could explain the possible role of herpesvirus infection in the development of thyroid autoimmune responses.

Material-methods: Thyroid tissue specimens were obtained postoperatively from 4 patients with multinodular goiter and 18 patients with autoimmune thyroid disease (Graves’ disease and Hashimoto thyroiditis). Herpes virus DNA was detected using polymerase chain reaction based assays.

Results: No statistically significant differences were observed between autoimmune thyroid disease and multinodular goiter tissue specimens concerning herpes simplex virus type 1, 2 DNA isolation (44.4% vs 0%, P=0.094), human herpes virus type 6 DNA isolation (11.1% vs 0%, P=0.48), human herpes virus type 7 DNA isolation (33.3% vs 25%, P=0.75). No CMV DNA was isolated from any tissue specimen. At least one kind of herpes virus DNA was detected in 13 out of 18 (72.22%) AITD tissue specimens and in 1 out of 4 (25%) MNG tissue specimens (P=0.01).

Conclusions: Although no data are available relating the direct effect of herpes infection on thyroid epithelial cells, a better understanding of how an aberrant immune response against the thyroid gland is initiated and propagated through herpes virus infection is required. Elucidation of the underlying mechanisms may allow the development of new etiologically based therapeutic modalities.

Key words

autoimmune thyroid disease - herpes virus - thyroidectomy - tissue specimens

References

• 1 Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y. The influence of human leucocyte antigen (HLA) genes on autoimmune thyroid disease (AITD): results of studies in HLA-DR3 positive AITD families.  Clin Endocrinol (Oxf). 2002;  57 81-88
• 2 Bauer HM, Ting CE, Greer JC, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM. Genital human papillomavirus infection in female university students as determined by a PCR-based method.  JAMA. 1991;  265 472-477
• 3 Caruso A, Favilli F, Rotola A, Comar M, Horejsh D, Alessandri G, Grassi M, Di Luca D, Fiorentini S. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures.  J Med Virol. 2003;  70 451-458
• 4 Coyle PV, Wyatt D, Connolly JH, O’Brien C. Epstein-Barr virus infection and thyroid dysfunction.  Lancet. 1989;  2 899
• 5 Dayan CM, Daniels CH. Chronic autoimmune thyroiditis.  N Engl J Med. 1996;  335 99-107
• 6 Fan JL, Desai RK, Dallas JS, Wagle JM, Seetharamaiah GS, Prabakar BS. High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves’ disease.  Clin Immunol Immunopathol. 1994;  71 69-74
• 7 Fountoulakis S, Tsatsoulis A. On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis.  Clin Endocrinol (Oxf). 2004;  60 397-409
• 8 Gianoukakis AG, Douglas RS, King CS, Cruikshank WW, Smith TJ. Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: a putative mechanism for T-cell infiltration of the thyroid in autoimmune disease.  Endocrinology. 2006;  147 1941-1949
• 9 Gosselin J, Tomolu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response.  Blood. 1999;  94 4210-4219
• 10 Hanafusa T, Pujol-Borrell R, Chiovato L, Russel RCG, Doniach D, Bottazzo GF. Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity.  Lancet. 1983;  2 1111-1115
• 11 Heward JM, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson PM, Sheppard MC, Barnett AH, Franklyn JA, Gough SC. Linkage disequilibrium between the human leucocyte antigen class II region of the major histocompatibility complex and Grave's disease: replication using a population case control and family based study.  J Clin Endocrinol Metab. 1998;  83 3394-3397
• 12 Horwitz MS, Sarvetnick M. Viruses, host responses, and autoimmunity.  Immunol Rev. 1999;  169 241-253
• 13 Inoue Y, Yasukawa M, Fujita S. Induction of T cell apoptosis by human herpesvirus type 6.  J Virol. 1997;  71 3751-3759
• 14 Ito M, Watanabe M, Kamiya H, Sakurai M. Herpes simplex virus type 1 induces apoptosis in peripheral blood T lymphocytes.  J Infect Dis. 1997;  175 1220-1224
• 15 Khoury EL, Pereira L, Greenspan FS. Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro.  Am J Pathol. 1991;  138 1209-1223
• 16 Krueger GR, Koch B, Leyssens N, Berneman Z, Rojo J, Horwitz C, Sloots T, Margalith M, Conradie JD, Imai S, Urasinski I, De Bruyere M, Ferrer Argote V, Krueger J. Comparison of seroprevalences of human herpes virus-6 and -7 in healthy blood donors from nine countries.  Vox Sang. 1998;  75 193-197
• 17 Meyers-Elliott RH, Pettit TH, Maxwell A. Viral antigens in the immune ring of herpes simplex stromal keratitis.  Arch Opthalmol. 1980;  98 897-904
• 18 Mikloska A, Cunningham AL. Herpes simplex virus type 1 glycoproteins gB, gC, and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes.  J Gen Virol. 1998;  79 353-361
• 19 Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. Probing the normal and autoimmune B cell repertoire with Epstein-Barr virus. Frequency of B cells producing monoreactive high affinity autoantibodies in patients with Hashimoto's disease and systemic lupus erythematosus.  J Immunol. 1988;  141 4165-4172
• 20 Oldstone MB. Molecular mimicry and autoimmune response.  Cell. 1987;  50 819-820
• 21 Pamphilon DH, Rider JR, Barbara JA, Williamson LM. Prevention of transfusion-transmitted cytomegalovirus infection.  Transfus Med. 1999;  9 115-123
• 22 Rodien P, Madec AM, Ruf J, Rajas F, Bornet H, Carayon P, Orgiazzi J. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies.  J Clin Endocrinol Metab. 1996;  81 2595-2600
• 23 Roizmann B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studert MJ. The family Herpesviridae: an update. The Herpesvirus Study Group of the International Committee.  Arch Virol. 1992;  123 425-449
• 24 Sanfilippo CM, Chirimuuta FNW, Blaho JA. Herpes simplex virus type 1 early gene expression is required for the induction of apoptosis in human epithelial Hep-2 cells.  J Virol. 2004;  78 224-239
• 25 Scotet E, Peyrat MA, Saulquin M, Retiere C, Couedel C, Davodeau F, Dulphy N, Toubert A, Bignon JD, Lim A, Vie H, Hallet MM, Liblau R, Weber M, Berthelo JM, Houssaint E, Bonneville M. Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes.  Eur J Immunol. 1999;  29 973-985
• 26 Thomas D, Michou V, Moustakarias T, Aleporou V, Matzavinos T, Mitsakos-Barbagiannis K, Kalofoutis A, Tsilivakos V. Altered immunophenotypic parameters in infertile women. Possible role of herpes viremia.  Am J Reprod Immunol. 2005;  54 101-111
• 27 Tomer Y, Davies TF. Infection, thyroid disease, and autoimmunity.  Endocr Rev. 1993;  14 107-120
• 28 Trgovcich J, Johnson D, Roizman B. Cell surface major histocompatibility complex class II proteins are regulated by the products of the γ143.5 and UL41 genes of herpes simplex virus 1.  J Virol. 2002;  76 6974-6986
• 29 Vrbikova J, Janatkova I, Zamrazil V, Tomiska F, Fucikova T. Epstein-Barr serology in patients with autoimmune thyroiditis.  Exp Clin Endocrinol Diabetes. 1996;  104 89-92
• 30 Wallace HL, Natelson B, Gause W, Hay J. Human Herpes viruses in Chronic Fatigue Syndrome.  Clin Diag Lab Immunol. 1999;  6 216-223
• 31 Weetman AP, MacGregor AM. Autoimmune thyroid disease: further developments in our understanding.  Endocr Rev. 1994;  15 788-783
• 32 Weetman AP. Graves’ disease.  N Engl J Med. 2000;  343 1236-1248
• 33 Xu F, Schillinger JA, Sternberg MR, Johnson RE, Lee FK, Nahmias AJ, Markowitz LE. Seroprevalence and co-infection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.  J Infect Dis. 2002;  185 1019-1024

Correspondence